Assembly Biosciences, Inc. (ASMB)
USD 13.51
(-5.39%)
USD 13.51
(-5.39%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 22.74 Million | -84.46 Million | -93.39 Million | -62.95 Million | -84.06 Million | -64.95 Million |
| Net Income | -61.22 Million | -93.09 Million | -129.85 Million | -62.15 Million | -97.63 Million | -90.75 Million |
| Depreciation & Amortization | 450 Thousand | 498 Thousand | 466 Thousand | 691 Thousand | 494 Thousand | 643 Thousand |
| Deferred income taxes | -7.15 Million | - | -2.53 Million | -4000.00 | -774 Thousand | 1.09 Million |
| Stock-based compensation | 5.11 Million | 6.59 Million | 5.23 Million | 21.85 Million | 20.55 Million | 28.48 Million |
| Change in working capital | 76.34 Million | -2.12 Million | -11.4 Million | -30.3 Million | -9.52 Million | -4.2 Million |
| Other non-cash items | 9.21 Million | 3.66 Million | 44.68 Million | 6.96 Million | 2.81 Million | -229 Thousand |
| Investing Cash Flow | -69.13 Million | 90.64 Million | 26.51 Million | 68.07 Million | -50.31 Million | -135.39 Million |
| Investments in PPE | -255 Thousand | -102 Thousand | -3.09 Million | -2.22 Million | -1.55 Million | -340 Thousand |
| Acquisitions | 24 Thousand | 1.5 Million | 1.5 Million | 1.75 Million | -1.73 Million | -48.88 Million |
| Investment purchases | -133.92 Million | -27.58 Million | -160.44 Million | -193.18 Million | -281.33 Million | -183.94 Million |
| Sales/Maturities of investments | 65.01 Million | 116.82 Million | 187.7 Million | 263.47 Million | 232.57 Million | 48.88 Million |
| Other Investing Activities | -68.88 Million | 90.74 Million | 857 Thousand | -1.75 Million | 1.73 Million | 48.88 Million |
| Financing Cash Flow | 13.81 Million | 614 Thousand | 53.06 Million | 7.59 Million | 139.64 Million | 159.79 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 13.81 Million | 325 Thousand | 52.8 Million | 5.45 Million | 134.66 Million | 159.79 Million |
| Other Financing Activities | 13.81 Million | 289 Thousand | 258 Thousand | 2.14 Million | 4.98 Million | 159.79 Million |
| Accounts receivables | 901 Thousand | -608 Thousand | 894 Thousand | 2.14 Million | -944 Thousand | -156 Thousand |
| Accounts payables | -2.03 Million | -166 Thousand | -1.93 Million | 2.86 Million | -1.96 Million | 1.56 Million |
| Inventory | - | - | -4.1 Million | -7.25 Million | -3 Million | -601 Thousand |
| Other working capital | 77.47 Million | -1.34 Million | -6.25 Million | -28.06 Million | -3.61 Million | -5.01 Million |
| Cash at beginning of period | 52.41 Million | 45.62 Million | 59.44 Million | 46.73 Million | 41.47 Million | 82.03 Million |
| Cash at end of period | 19.84 Million | 52.41 Million | 45.62 Million | 59.44 Million | 46.73 Million | 41.47 Million |
| Capital Expenditure | -255 Thousand | -102 Thousand | -3.09 Million | -2.22 Million | -1.55 Million | -340 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -32.57 Million | 6.79 Million | -13.81 Million | 12.71 Million | 5.26 Million | -40.56 Million |
| Free Cash Flow | 22.48 Million | -84.56 Million | -96.49 Million | -65.17 Million | -85.62 Million | -65.29 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.15 Million | -9.07 Million | -10.96 Million | -61.22 Million | -14.42 Million | -16.89 Million |
| Depreciation & Amortization | 32 Thousand | 32 Thousand | 84 Thousand | 450 Thousand | 116 Thousand | 126 Thousand |
| Deferred income taxes | - | - | -1.46 Million | -7.15 Million | -313 Thousand | -169 Thousand |
| Stock-based compensation | 833 Thousand | 739 Thousand | 959 Thousand | 5.11 Million | 1.13 Million | 1.19 Million |
| Change in working capital | -6.2 Million | -9.15 Million | 83.49 Million | 76.34 Million | -880 Thousand | 4.39 Million |
| Other non-cash items | 174 Thousand | -368 Thousand | 1.53 Million | 9.21 Million | 514 Thousand | -2.27 Million |
| Investing Cash Flow | 5.1 Million | 17.27 Million | -89.65 Million | -69.13 Million | 18.88 Million | -8.36 Million |
| Investments in PPE | -14 Thousand | -14 Thousand | -71 Thousand | -255 Thousand | -136 Thousand | -48 Thousand |
| Acquisitions | - | - | 24 Thousand | 24 Thousand | -19.01 Thousand | 48 Thousand |
| Investment purchases | -31.17 Million | -3.71 Million | -108.3 Million | -133.92 Million | -2.65 Million | -22.96 Million |
| Sales/Maturities of investments | 36.3 Million | 21 Million | 18.7 Million | 65.01 Million | 21.67 Million | 14.64 Million |
| Other Investing Activities | 5.12 Million | 1.26 Million | -89.58 Million | -68.88 Million | 19.01 Thousand | -48 Thousand |
| Financing Cash Flow | 12.45 Million | - | 9.19 Million | 13.81 Million | - | 134 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 12.45 Million | - | 9.19 Million | 13.81 Million | - | 54 Thousand |
| Other Financing Activities | 12.45 Million | - | 9.19 Million | 13.81 Million | - | 80 Thousand |
| Accounts receivables | 43 Thousand | - | -43 Thousand | 901 Thousand | 342 Thousand | 375 Thousand |
| Accounts payables | 74 Thousand | 266 Thousand | -297 Thousand | -2.03 Million | -146 Thousand | -320 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -6.32 Million | -9.41 Million | 83.83 Million | 77.47 Million | -1.07 Million | 4.33 Million |
| Cash at beginning of period | 18.74 Million | 19.84 Million | 23.96 Million | 52.41 Million | 21.62 Million | 43.48 Million |
| Cash at end of period | 19.2 Million | 18.74 Million | 19.84 Million | 19.84 Million | 26.65 Million | 21.62 Million |
| Capital Expenditure | -14 Thousand | -14 Thousand | -71 Thousand | -255 Thousand | -136 Thousand | -48 Thousand |
| Effect of forex changes on cash | - | - | 2.69 Million | - | - | 23.04 Million |
| Net cash flow / Change in cash | 459 Thousand | -1.09 Million | -4.11 Million | -32.57 Million | 5.03 Million | -21.85 Million |
| Free Cash Flow | -17.11 Million | -18.37 Million | 73.57 Million | 22.48 Million | -13.98 Million | -13.67 Million |
PBCO
7844
6661
CNRFF
VLGEA
CTAGF